BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 395539)

  • 1. Aminoglycoside renal cortical kinetics: a clue to mechanisms of nephrotoxicity.
    Whelton A
    Prog Clin Biol Res; 1979; 35():33-41. PubMed ID: 395539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prediction of aminoglycoside nephrotoxicity (author's transl)].
    Whelton A
    Nouv Presse Med; 1978 Nov; 7(42):3838-43. PubMed ID: 714689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the intrarenal disposition of tobramycin and gentamicin: therapeutic and toxicologic answers.
    Whelton A; Carter GG; Craig TJ; Bryant HH; Herbst DV; Walker WG
    J Antimicrob Chemother; 1978 May; 4 Suppl A():13-22. PubMed ID: 26653
    [No Abstract]   [Full Text] [Related]  

  • 4. [Aminoglycoside nephrotoxicity. I. Clinical aspects, morphology and tissue pharmacokinetics].
    Fabre J
    Nephrologie; 1980; 1(1):37-43. PubMed ID: 7029331
    [No Abstract]   [Full Text] [Related]  

  • 5. Dibekacin intrarenal distribution characteristics and renal cortical elution kinetics. Comparison with gentamicin and tobramycin.
    Whelton A; Carter GG; Stout RL; Herbst DV; Bryant HH; Walker G
    J Clin Pharmacol; 1980; 20(8-9):518-25. PubMed ID: 7430416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aminoglycoside nephrotoxicity--a tale of two transports.
    Whelton A; Solez K
    J Lab Clin Med; 1982 Feb; 99(2):148-55. PubMed ID: 7038007
    [No Abstract]   [Full Text] [Related]  

  • 7. Aminoglycoside nephrotoxicity: pathogenesis and prevention.
    Cronin RE
    Clin Nephrol; 1979 May; 11(5):251-6. PubMed ID: 378495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glomerular nephrotoxicity of aminoglycosides.
    Martínez-Salgado C; López-Hernández FJ; López-Novoa JM
    Toxicol Appl Pharmacol; 2007 Aug; 223(1):86-98. PubMed ID: 17602717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of the renal cortical uptake and release of aminoglycosides: a rational approach to the understanding and prevention of their nephrotoxicity.
    Giuliano RA; Verpooten GA; De Broe ME
    Dev Toxicol Environ Sci; 1986; 14():105-14. PubMed ID: 3829968
    [No Abstract]   [Full Text] [Related]  

  • 10. Targeted prevention of renal accumulation and toxicity of gentamicin by aminoglycoside binding receptor antagonists.
    Watanabe A; Nagai J; Adachi Y; Katsube T; Kitahara Y; Murakami T; Takano M
    J Control Release; 2004 Mar; 95(3):423-33. PubMed ID: 15023454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetics and nephrotoxicity of aminoglycoside antibiotics].
    Marino A; Pisanti N
    Clin Ter; 1989 Jun; 129(6):421-8. PubMed ID: 2526703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminoglycosides: assessing the potential for nephrotoxicity.
    Wilson SE
    Surg Gynecol Obstet; 1990; 171 Suppl():24-30. PubMed ID: 2244292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atractyloside nephrotoxicity: in vitro studies with suspensions of rat renal fragments and precision-cut cortical slices.
    Obatomi DK; Bach PH
    In Vitr Mol Toxicol; 2000; 13(1):25-36. PubMed ID: 10900405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephrotoxicity of aminoglycosides and cephalosporins in combination.
    Rankin GO; Sutherland CH
    Adverse Drug React Acute Poisoning Rev; 1989; 8(2):73-88. PubMed ID: 2672726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prediction of aminoglycoside nephrotoxicity].
    Lucht F; Peyramond D; Robert D; Vincent P
    Sem Hop; 1982 Sep; 58(35):2021-5. PubMed ID: 6293091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of renal membrane binding and nephrotoxicity of aminoglycosides.
    Williams PD; Hottendorf GH; Bennett DB
    J Pharmacol Exp Ther; 1986 Jun; 237(3):919-25. PubMed ID: 3754895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study on renal accumulation of aminoglycoside antibiotics.
    Fujita K; Fujita HM
    Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):47-51. PubMed ID: 3988393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The differentiation of potential nephrotoxicity of various aminoglycosides in animal experiments].
    Sack K; Freiesleben H; Züllich B; Beck H; Schulz E
    Adv Clin Pharmacol; 1978; 15():69-90. PubMed ID: 676878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular-targeted approaches to reduce renal accumulation of nephrotoxic drugs.
    Nagai J; Takano M
    Expert Opin Drug Metab Toxicol; 2010 Sep; 6(9):1125-38. PubMed ID: 20536274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanisms implied in aminoglycoside-induced nephrotoxicity].
    Morales AI; Arévalo M; Pérez-Barriocanal F
    Nefrologia; 2000; 20(5):408-14. PubMed ID: 11100661
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.